Bornlisy Attenuates Colitis-Associated Colorectal Cancer via Inhibiting GPR43-Mediated Glycolysis.
Bornlisy Attenuates Colitis-Associated Colorectal Cancer via Inhibiting GPR43-Mediated Glycolysis.
复制标题
Bornlisy 通过抑制 GPR43 介导的糖酵解来减轻结肠炎相关的结直肠癌
DOI:
10.3389/fnut.2021.706382
复制
发表时间:
2021
影响因子:
5
通讯作者:
Wang T
中科院分区:
文献类型:
--
作者:
Lu X;Qiao S;Peng C;Yan W;Xu Z;Qu J;Hou Y;Zhao S;Chen P;Wang T
There is evidence that probiotics have a broad antitumor effect in colorectal cancer (CRC). However, the mechanism remains obscure. Here, we investigated the effect of Bornlisy (BO)-cocktails of three probiotics on colitis-associated colon cancer (CAC) and the underlying mechanism. The treatment of CAC mice with BO resulted in decreased tumor loads as compared with their counterparts. BO also inhibited the proliferation and metastasis of CRC cells in vitro. Furthermore, BO inhibited cell proliferation through downregulating glycolysis. Activating glycolysis reversed the protective role of BO in the CAC mice. Mechanically, BO administration promoted the activation of GPR43, followed by its downstream PLC-PKC-ERK pathway, which led to decreased glucose metabolism. These results suggest that BO may provide an intervention strategy for CRC therapy, while GPR43 is a potential targeting receptor during the BO treatment.
登录
查看更多内容
影响因子:
29.4
作者:
Chen X;Fruehauf J;Goldsmith JD;Xu H;Katchar KK;Koon HW;Zhao D;Kokkotou EG;Pothoulakis C;Kelly CP
通讯作者:
Kelly CP
DOI:
10.3322/caac.21398
发表时间:
2017-07-08
期刊:
CA: a cancer journal for clinicians
影响因子:
--
作者:
Bhatt AP;Redinbo MR;Bultman SJ
通讯作者:
Bultman SJ
影响因子:
30.8
作者:
Huyghe, Jeroen R.;Bien, Stephanie A.;Peters, Ulrike
通讯作者:
Peters, Ulrike
影响因子:
4.8
作者:
Brown, AJ;Goldsworthy, SM;Dowell, SJ
通讯作者:
Dowell, SJ
影响因子:
29.4
作者:
Dekker, Evelien;Rex, Douglas K.
通讯作者:
Rex, Douglas K.